|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Financial assets measured at fair value through profit or loss | |||||||||
| Accounts receivable | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Inventories | |||||||||
| Assets held for sale | |||||||||
| Total current assets | |||||||||
| Non-current assets | |||||||||
| Vessels and drydock | |||||||||
| Right of use assets for vessels | |||||||||
| Other assets | |||||||||
| Goodwill | |||||||||
| Restricted cash | |||||||||
| Total non-current assets | |||||||||
| Total assets | |||||||||
| Current liabilities | |||||||||
| Current portion of long-term bank debt | |||||||||
| Sale and leaseback liability | |||||||||
| IFRS 16 - lease liability | |||||||||
| Accounts payable | |||||||||
| Accrued expenses and other current liabilities | |||||||||
| Total current liabilities | |||||||||
| Non-current liabilities | |||||||||
| Long-term bank debt and bonds | |||||||||
| Sale and leaseback liability | |||||||||
| IFRS 16 - lease liability | |||||||||
| Other long-term liabilities | |||||||||
| Total non-current liabilities | |||||||||
| Total liabilities | |||||||||
| Shareholders’ equity | |||||||||
| Common stock, $0.01 par value per share; 150,000,000 and 150,000,000 shares authorized; 51,762,790 and 49,923,042 outstanding shares as of December 31, 2025 and December 31, 2024, respectively. | |||||||||
| Additional paid-in capital | |||||||||
| Treasury shares | |||||||||
| Retained earnings | |||||||||
| Total shareholders’ equity | |||||||||
| Total liabilities and shareholders’ equity | |||||||||
Loading...
